An evaluation of no-treatment decisions in patients with newly diagnosed acute myeloid leukemia

被引：2

作者：

Brandwein, Joseph M. ^{[1
]}

Hallett, Darren ^{[1
]}

Karkhaneh, Mohammad ^{[2
]}

Zhu, Nancy ^{[1
]}

Liew, Elena ^{[1
]}

Bolster, Lauren ^{[1
]}

Hamilton, Marlene ^{[1
]}

Patterson, Jeffrey ^{[1
]}

Taparia, Minakshi ^{[1
]}

Wu, Cynthia ^{[1
]}

Van Slyke, Tiffany ^{[1
]}

Bankar, Aniket ^{[1
]}

Saini, Lalit ^{[3
]}

机构：

[1] Univ Alberta, Dept Med, Edmonton, AB, Canada

[2] Inst Hlth Econ, Edmonton, AB, Canada

[3] London Hlth Sci Ctr, Dept Med, London, ON, Canada

来源：

AMERICAN JOURNAL OF HEMATOLOGY | 2021年 / 96卷 / 01期

关键词：

OUTCOMES;

D O I：

10.1002/ajh.26012

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E17 / E20

页数：5

共 50 条

[21] Indirect Treatment Comparison of Ivosidenib and Other Therapies in Patients with Newly Diagnosed Acute Myeloid Leukemia
Gil-Sierra, Manuel David
Mantopoulos, Theo
Barouma, Ifigeneia
Hauch, Ole
Teng, Zhaoyang
Fernandez, Cedric
Corbet, Sean
Schlueter, Max
BLOOD, 2024, 144 : 5196 - 5197
[22] Updates in the Management of Newly Diagnosed Acute Myeloid Leukemia
Mims, Alice S.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2021, 19 (11.5): : 1358 - 1361
[23] The Cup Runneth Over: Treatment Strategies for Newly Diagnosed Acute Myeloid Leukemia
Cooperrider, Jennifer H.
Shukla, Navika
Nawas, Mariam T.
Patel, Anand Ashwin
JCO ONCOLOGY PRACTICE, 2023, 19 (02) : 74 - +
[24] Outcomes of decitabine treatment for newly diagnosed acute myeloid leukemia in older adults
Yoo, Kwai Han
Cho, Jinhyun
Han, Boram
Kim, Se Hyung
Shin, Dong-Yeop
Hong, Junshik
Kim, Hawk
Kim, Hyo Jung
Zang, Dae young
Yoon, Sung-Soo
Jin, Jong-Youl
Lee, Jae Hoon
Hong, Dae-Sik
Park, Seong Kyu
PLOS ONE, 2020, 15 (08):
[25] Venetoclax-based combinations for the treatment of newly diagnosed acute myeloid leukemia
Othman, Tamer A.
Azenkot, Tali
Moskoff, Benjamin N.
Tenold, Matthew E.
Jonas, Brian A.
FUTURE ONCOLOGY, 2021, 17 (23) : 2989 - 3005
[26] Treatment Choice of Decitabine Versus Conventional Chemotherapy for the Treatment of Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia
Park, Hyunsung
Cho, Hyunsoo
Lee, Jungyeon
Jang, Jieun
Kim, Yundeok
Kim, Soo Jeong
Kim, Yu Ri
Kim, Jin Seok
Min, Yoo Hong
Cheong, June-Won
BLOOD, 2015, 126 (23)
[27] SOCS1 methylation in patients with newly diagnosed acute myeloid leukemia
Chen, CY
Tsay, W
Tang, JL
Shen, HL
Lin, SW
Huang, SY
Yao, M
Chen, YC
Shen, MC
Wang, CH
Tien, HF
GENES CHROMOSOMES & CANCER, 2003, 37 (03): : 300 - 305
[28] Healthcare resource utilization and costs in patients with newly diagnosed acute myeloid leukemia
Hagiwara, May
Sharma, Arati
Chung, Karen C.
Delea, Thomas E.
JOURNAL OF MEDICAL ECONOMICS, 2018, 21 (11) : 1119 - 1130
[29] Racial Variations in Mutational Profile in Newly Diagnosed Acute Myeloid Leukemia Patients
Anwar, Tahsin
Mian, Mohammed
Shoukier, Mahran
Guddati, Achuta K.
Hossain, Moinul
Kolhe, Ravindra
Bryan, Locke J.
Jillella, Anand P.
Cortes, Jorge E.
Kota, Vamsi
BLOOD, 2020, 136
[30] How we use venetoclax with hypomethylating agents for the treatment of newly diagnosed patients with acute myeloid leukemia
Brian A. Jonas
Daniel A. Pollyea
Leukemia, 2019, 33 : 2795 - 2804

← 1 2 3 4 5 →